A Single-Dose Study of MK6349 in Patients With Type 2 Diabetes (6349-002)
Clinical trial NCT00943371 · TERMINATED
Trial details
- NCT number
- NCT00943371
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2007-09-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.